RESTEGHINI, CARLO
RESTEGHINI, CARLO
Universita' degli Studi di MILANO
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2
2025 P. Rondi, D. Mattavelli, V. Rampinelli, A. Schreiber, E. Orlandi, B. Vischioni, N.A. Iacovelli, G. Calareso, C. Bergamini, S. Alfieri, P. Castelnuovo, P. Battaglia, M. Turri-Zanoni, P. Nicolai, M. Ferrari, L. Licitra, P. Bossi, D. Farina, M. Ravanelli, C. Resteghini
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials
2025 C. Gurizzan, M. Cinquini, L. Legramandi, C. Resteghini, M. Siano, C. Bergamini, L. Lorini, D. Smussi, A. Paderno, L. Licitra, P. Bossi
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era
2025 A. Alberti, C. Gurizzan, C. Resteghini, A. Trama, A. Bernasconi, S. Grisanti, M. Zamparini, I. Mohamad, I. Linares Galiana, E. Ozyar, P. Franco, S. Vecchio, P. Bonomo, B. Cirauqui, M. El-Sherify, S. Ursino, A. Argiris, J. Pan, C. Wittekindt, E. D'Angelo, L. Costa, M. Buglione, J.M. Johnson, M. Airoldi, R. Mesia, L. Licitra, E. Orlandi, P. Bossi
Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
2025 C. Resteghini, B. Baujat, P. Bossi, A. Franchi, L. De Gabory, J. Halamkova, F. Haubner, J.A.U. Hardillo, M.A. Hermsen, N.A. Iacovelli, R. Maroldi, S. Mattheis, A. Moya-Plana, P. Nicolai, E. Orlandi, J. Thariat, A. Trama, M.W.M. Van Den Brekel, C.M.L. Van Herpen, B. Verillaud, E. Kinloch, L. Licitra, C. Even
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study
2025 S. Rota, S. Buriolla, A. Franza, S. Cavalieri, C. Bergamini, S. Alfieri, I. Nuzzolese, E. Colombo, A. Ottini, B. Lombardi Stocchetti, G. Massa, A. Caraceni, L. Licitra, C. Resteghini
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study
2025 E. Colombo, S. Cavalieri, A. Vingiani, L. Agnelli, M. Duca, B. Paolini, F. Perrone, E. Tamborini, I. Capone, A. Piccolo, F. Caspani, C. Bergamini, S. Alfieri, C. Resteghini, I. Nuzzolese, A. Ottini, S. Buriolla, M. Salvetti, G. Calareso, M. Milione, G. Pruneri, L.D. Locati, L. Licitra
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers
2025 F. Caspani, S. Cavalieri, E. Orlandi, C. Bergamini, C. Resteghini, E. Colombo, A. Ottini, I. Nuzzolese, S. Alfieri, A. Mirabile, A. Cassano, P. Bossi, T. Ibrahim, M.C. Cau, M. Ghiani, F. Bertolini, R. Ingargiola, G. Fontana, L. Licitra, L.D. Locati
Management of patients with skin adnexal carcinomas
2023 S. Cavalieri, C. Bergamini, S. Alfieri, C. Resteghini, I. Nuzzolese, E. Colombo, A. Ottini, L. Licitra
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience
2023 S. Cavalieri, F. Platini, F. Barretta, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, N.A. Iacovelli, M. Franceschini, G. Calareso, P. Di Pede, G. De Feo, M. Gandelli, L. Toffolatti, M. Guglielmo, C.I. Ripamonti, L. Cosmai, L. Licitra, S. Alfieri
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports
2023 E. Colombo, C. Gurizzan, A. Ottini, F. Caspani, C. Bergamini, L.D. Locati, C. Marchiselli, A. Alberti, L. Lorini, L.F. Licitra, P. Bossi, C. Resteghini
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
2023 S. Cavalieri, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, S. Alfieri, P. Quattrone, G. Calareso, N.A. Iacovelli, M. Franceschini, L. Licitra
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients
2022 S. Cavalieri, P. Bossi, G. Infante, R. Miceli, N.A. Iacovelli, E. Ivaldi, L.D. Locati, C. Bergamini, C. Resteghini, I. Nuzzolese, S. Alfieri, E. Colombo, R. Ingargiola, M. Franceschini, G. Calareso, L. Licitra, E. Orlandi
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy
2022 V.D.A. Corino, M. Bologna, G. Calareso, C. Resteghini, S. Sdao, E. Orlandi, L. Licitra, L. Mainardi, P. Bossi
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort
2021 P. Bossi, A. Trama, A. Bernasconi, S. Grisanti, I. Mohamad, I.L. Galiana, E. Ozyar, P. Franco, S. Vecchio, P. Bonomo, B.C. Cirauqui, M. El-Sherify, S. Ursino, A. Argiris, J. Pan, C. Wittekindt, E. D’Angelo, L. Costa, M. Buglione, J. Johnson, M. Airoldi, R. Mesia, C. Resteghini, L. Licitra, E. Orlandi
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic
2021 S. Cavalieri, E. Colombo, A. Bottiglieri, G. Massa, F. Platini, A. Ottini, D. Filippini, E. Zattarin, C. Bergamini, C. Resteghini, S. Alfieri, V. Di Martino, V. Tiraferri, L. Locati, L. Licitra
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
2021 S. Cavalieri, D.M. Filippini, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, R. Lombardo, I. Nuzzolese, S. Alfieri, L. Licitra, L.D. Locati
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions
2021 P. Economopoulou, A. Pantazopoulos, A. Spathis, I. Kotsantis, A. Kyriazoglou, G. Kavourakis, R. Zakopoulou, I. Chatzidakis, M. Anastasiou, M. Prevezanou, C. Resteghini, L. Licitra, C. Bergamini, E. Colombo, F. Caspani, N. Denaro, S. Vecchio, P. Bonomo, M.C. Rocca, F. Bertolini, D. Ferrari, A. Psyrri, P. Bossi
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer
2020 M. Bologna, G. Calareso, C. Resteghini, S. Sdao, E. Montin, V. Corino, L. Mainardi, L. Licitra, P. Bossi
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands
2020 S. Cavalieri, L. Mariani, V. Vander Poorten, L. Van Breda, M.C. Cau, S. Lo Vullo, S. Alfieri, C. Resteghini, C. Bergamini, E. Orlandi, G. Calareso, P. Clement, E. Hauben, F. Platini, P. Bossi, L. Licitra, L.D. Locati
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach
2019 E. Orlandi, S. Cavalieri, R. Granata, P. Nicolai, P. Castelnuovo, C. Piazza, A. Schreiber, M. Turri-Zanoni, P. Quattrone, R. Miceli, G. Infante, F. Sessa, C. Facco, G. Calareso, N.A. Iacovelli, D. Mattavelli, A. Paderno, C. Resteghini, L.D. Locati, L. Licitra, P. Bossi